Our achievements in research projects made in close collaboration with our partners are published in peer reviewed journals.
News &
Strategic Partnership of EVOMEDIS GmbH, Medical University and COREMED Graz
Investing in the future of burn medicine: Alliance develops new cell-based therapy in Graz to Foster Wound Healing Innovations
Read More
European Commission grants orphan drug designation for EVOCellic
Important milestone: EVOMEDIS has received Orphan Drug Designation from the European Medicines Agency (EMA) for its novel cell therapy drug for the treatment of severe burns.
Read More
burns, 2020
A novel human ex-vivo burn model and the local cooling effect of a bacterial nanocellulose-based wound dressing
Read More
burns, 2019
Delivery of antiseptic solutions by a bacterial cellulose wound dressing: Uptake, release and antibacterial efficacy of octenidine and povidone-iodine
Read More
burns, 2019
Experience with Epifast® cryopreserved epidermal allograft in the treatment of superficial and deep second-degree burns: Retrospective study of 297 cases, 2010–2015
Read More
burns, 2019
Continuous pH monitoring in wounds using a composite indicator dressing — A feasibility study
Read More
burns, 2018
Uptake of PHMB in a bacterial nanocellulose-based wound dressing: A feasible clinical procedure
Read More
Join our open clinical network and profit from our devolpment expertise.